Home
Search
Site map
Please choose
Austria
Belgium
Bulgaria
Canada
Denmark
Finland
France
Germany
Italy
Lithuania
Luxembourg
Malta
Norway
Spain
Switzerland
United Kingdom
Corporate
Corporate information
Board of Directors
Mr. Werner Henrich
Mr. Hans-Beat Gürtler
Prof. Daniel Lew
Dr. Thomas M. Rinderknecht
Mr. Domenico Scala
Mr. Claude Schreiner
Mr. Steven D. Skolsky
Dr. Thomas Werner
Management Committee
Dr. Anthony Man
Mr. Joachim Blatter
Dr. Ingrid Heinze-Krauss
Prof. Achim Kaufhold
Dr. Laurenz Kellenberger
Mr. Hans Christian Rohde
Mr. Ronald Scott
Company and subsidiaries
Patient Advocacy
Products
Toctino®
Austria
Belgium
Bulgaria
Canada
Denmark
Finland
France
Germany
Italy
Lithuania
Luxembourg
Malta
Norway
Spain
Switzerland
United Kingdom
Austria
Belgium
Bulgaria
Canada
Denmark
Finland
France
Germany
Italy
Lithuania
Luxembourg
Malta
Norway
Spain
Switzerland
United Kingdom
Development
Pipeline
Ceftobiprole
Alitretinoin
Isavuconazole
BAL30072
BAL101553
Research
Research strategy
Anti-infectives research
Oncology research
Research center China
Featured bugs
Pathogens
News and Media
News
Media contact
Scientific publications
Anti-infectives
2010
2009
2008
2007
2006
2005
2004
2003
2002
Archive
Dermatology
2010
2009
2008
2007
2005
2004
Archive
Oncology
2010
2009
Investor Relations
Corporate information
Corporate Governance
News and Media
Financial reports
Pipeline
Share information
Investors calendar
Investor Relations contact
News subscription
Careers
Contact us
Corporate
How to find us
Investor Relations / Media
Human Resources
Collaborations
Corporate
Corporate information
Board of Directors
Management Committee
Company and subsidiaries
Patient Advocacy
Search
›› go!
Patient Advocacy
In compliance with the EFPIA code of practice on relationships between the pharmaceutical industry and patient organizations Basilea Pharmaceutica International Ltd. discloses its collaborations for 2010.
Downloads
Patient advocacy 2010
[46 kb]
Info
Printable Version